Maintenance fees coming due
6 maintenance fees come due in the 12 months from Nov 16, 2026, the next on Dec 13, 2026. Unpaid by Jun 14, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 11,673,902 | Isoindolinone and Indazole Compounds for the Degradation of Egfr In force Fee due Dec 13, 2026 Lapses if unpaid Jun 14, 2027 · High confidence | C4 Therapeutics, Inc. | In force | Dec 13, 2026 | Jun 14, 2027 | High confidence | |
| US 11,691,972 | Compounds for Targeted Degradation of BRD9 In force Fee due Jan 4, 2027 Lapses if unpaid Jul 6, 2027 · High confidence | C4 Therapeutics, Inc. | In force | Jan 4, 2027 | Jul 6, 2027 | High confidence | |
| US 11,753,397 | Cereblon Binders for the Degradation of Ikaros In force Fee due Mar 12, 2027 Lapses if unpaid Sep 13, 2027 · High confidence | C4 Therapeutics, Inc. | In force | Mar 12, 2027 | Sep 13, 2027 | High confidence | |
| US 11,787,802 | Dihydrobenzimidazolones for Medical Treatment In force Fee due Apr 17, 2027 Lapses if unpaid Oct 18, 2027 · High confidence | C4 Therapeutics, Inc. | In force | Apr 17, 2027 | Oct 18, 2027 | High confidence | |
| US 11,802,131 | Glutarimides for Medical Treatment In force Fee due Apr 30, 2027 Lapses if unpaid Nov 1, 2027 · High confidence | C4 Therapeutics, Inc. | In force | Apr 30, 2027 | Nov 1, 2027 | High confidence | |
| US 10,646,575 | Heterocyclic Degronimers for Target Protein Degradation In force Fee due Nov 12, 2027 Lapses if unpaid May 12, 2028 · High confidence | C4 Therapeutics, Inc. | In force | Nov 12, 2027 | May 12, 2028 | High confidence |
6 of 6 patents shown. Soonest fee due date first, then patent number.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.